Vespula pensylvanica isolate Volc-1 chromosome 19, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025354.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
pancreatic lipase-related protein 2-like, transcript variant X1
pancreatic lipase-related protein 2-like, transcript variant X2
pancreatic lipase-related protein 2-like isoform X1
pancreatic lipase-related protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
intraflagellar transport protein 52 homolog, transcript variant X1
intraflagellar transport protein 52 homolog, transcript variant X2
intraflagellar transport protein 52 homolog isoform X1
intraflagellar transport protein 52 homolog isoform X2
nuclear transcription factor Y subunit gamma-like
eyes absent homolog 4, transcript variant X2
eyes absent homolog 4, transcript variant X3
eyes absent homolog 4, transcript variant X4
eyes absent homolog 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ras-interacting protein RIP3-like, transcript variant X1
ras-interacting protein RIP3-like, transcript variant X6
ras-interacting protein RIP3-like, transcript variant X4
ras-interacting protein RIP3-like, transcript variant X2
ras-interacting protein RIP3-like, transcript variant X3
ras-interacting protein RIP3-like, transcript variant X5
ras-interacting protein RIP3-like isoform X2
ras-interacting protein RIP3-like isoform X1
ras-interacting protein RIP3-like isoform X4
ras-interacting protein RIP3-like isoform X3
ras-interacting protein RIP3-like isoform X5
coiled-coil and C2 domain-containing protein 1-like, transcript variant X4
coiled-coil and C2 domain-containing protein 1-like, transcript variant X2
coiled-coil and C2 domain-containing protein 1-like, transcript variant X3
coiled-coil and C2 domain-containing protein 1-like, transcript variant X1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X7
coiled-coil and C2 domain-containing protein 1-like isoform X4
coiled-coil and C2 domain-containing protein 1-like isoform X2
coiled-coil and C2 domain-containing protein 1-like isoform X3
coiled-coil and C2 domain-containing protein 1-like isoform X1
coiled-coil and C2 domain-containing protein 1-like isoform X7
coiled-coil and C2 domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coiled-coil and C2 domain-containing protein 1-like isoform X5
coiled-coil and C2 domain-containing protein 1-like, transcript variant X6
coiled-coil and C2 domain-containing protein 1-like isoform X6
DNA-directed RNA polymerase I subunit RPA1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small subunit processome component 20 homolog, transcript variant X2
small subunit processome component 20 homolog, transcript variant X1
small subunit processome component 20 homolog
probable cytochrome P450 305a1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
probable cytochrome P450 305a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable cytochrome P450 305a1 isoform X1
probable cytochrome P450 305a1 isoform X2
uncharacterized LOC122635797, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122635797, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122635733, transcript variant X1
uncharacterized LOC122635733, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized protein LOC122635733 isoform X1
uncharacterized protein LOC122635733 isoform X2
transmembrane emp24 domain-containing protein bai
iron-sulfur cluster assembly 2 homolog, mitochondrial
protein phosphatase 1 regulatory subunit 21, transcript variant X3
protein phosphatase 1 regulatory subunit 21, transcript variant X2
protein phosphatase 1 regulatory subunit 21, transcript variant X1
protein phosphatase 1 regulatory subunit 21 isoform X2
protein phosphatase 1 regulatory subunit 21 isoform X1
RNA-binding protein Musashi homolog 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2 isoform X1
RNA-binding protein Musashi homolog 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2 isoform X2
RNA-binding protein Musashi homolog 2 isoform X3
39S ribosomal protein L51, mitochondrial
glucose dehydrogenase [FAD, quinone]-like
cystinosin homolog, transcript variant X5
cystinosin homolog, transcript variant X1
cystinosin homolog, transcript variant X3
cystinosin homolog, transcript variant X4
cystinosin homolog, transcript variant X2
39S ribosomal protein L55, mitochondrial
uncharacterized LOC122635857, transcript variant X1
uncharacterized protein LOC122635857 isoform X1
uncharacterized LOC122635857, transcript variant X2
uncharacterized LOC122635857, transcript variant X3
uncharacterized protein LOC122635857 isoform X2
probable serine/threonine-protein kinase DDB_G0282963
guanine nucleotide-binding protein-like 3 homolog
cardioacceleratory peptide receptor-like, transcript variant X9
cardioacceleratory peptide receptor-like, transcript variant X1
cardioacceleratory peptide receptor-like, transcript variant X4
cardioacceleratory peptide receptor-like, transcript variant X3
cardioacceleratory peptide receptor-like, transcript variant X7
cardioacceleratory peptide receptor-like, transcript variant X10
cardioacceleratory peptide receptor-like, transcript variant X2
cardioacceleratory peptide receptor-like, transcript variant X8
cardioacceleratory peptide receptor-like, transcript variant X5
cardioacceleratory peptide receptor-like, transcript variant X6
cardioacceleratory peptide receptor-like isoform X1
cardioacceleratory peptide receptor-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain-containing family M member 2, transcript variant X1
pleckstrin homology domain-containing family M member 2 isoform X1
pleckstrin homology domain-containing family M member 2, transcript variant X2
uncharacterized protein LOC122635731 isoform X2
39S ribosomal protein L47, mitochondrial
uncharacterized LOC122635791, transcript variant X1
uncharacterized LOC122635791, transcript variant X3
uncharacterized LOC122635791, transcript variant X2
cilia- and flagella-associated protein 69-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
protocadherin-like wing polarity protein stan, transcript variant X2
protocadherin-like wing polarity protein stan, transcript variant X5
protocadherin-like wing polarity protein stan, transcript variant X1
protocadherin-like wing polarity protein stan, transcript variant X4
protocadherin-like wing polarity protein stan, transcript variant X3
protocadherin-like wing polarity protein stan isoform X1
protocadherin-like wing polarity protein stan isoform X2
dedicator of cytokinesis protein 3, transcript variant X1
dedicator of cytokinesis protein 3, transcript variant X2
dedicator of cytokinesis protein 3 isoform X2
dedicator of cytokinesis protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dihydrolipoyl dehydrogenase, mitochondrial
uncharacterized LOC122635736, transcript variant X1
uncharacterized LOC122635736, transcript variant X2
uncharacterized LOC122635736, transcript variant X3
uncharacterized protein LOC122635736 isoform X1
uncharacterized LOC122635736, transcript variant X4
uncharacterized protein LOC122635736 isoform X2
protein shisa-5-like, transcript variant X2
protein shisa-5-like, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X5
eukaryotic translation initiation factor 4 gamma 2, transcript variant X2
eukaryotic translation initiation factor 4 gamma 2, transcript variant X4
eukaryotic translation initiation factor 4 gamma 2, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X6
eukaryotic translation initiation factor 4 gamma 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2 isoform X1
eukaryotic translation initiation factor 4 gamma 2 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
ADP-ribosylation factor-like protein 1, transcript variant X2
ADP-ribosylation factor-like protein 1, transcript variant X1
ADP-ribosylation factor-like protein 1 isoform X1
ADP-ribosylation factor-like protein 1 isoform X2
DNA polymerase delta catalytic subunit, transcript variant X2
DNA polymerase delta catalytic subunit, transcript variant X1
DNA polymerase delta catalytic subunit, transcript variant X3
DNA polymerase delta catalytic subunit, transcript variant X4
DNA polymerase delta catalytic subunit, transcript variant X5
DNA polymerase delta catalytic subunit isoform X2
DNA polymerase delta catalytic subunit isoform X1
DNA polymerase delta catalytic subunit isoform X4
DNA polymerase delta catalytic subunit isoform X5
DNA polymerase delta catalytic subunit isoform X3
tyrosine-protein phosphatase corkscrew-like, transcript variant X2
tyrosine-protein phosphatase corkscrew-like, transcript variant X1
tyrosine-protein phosphatase corkscrew-like
60S ribosome subunit biogenesis protein NIP7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger MYND domain-containing protein 11, transcript variant X1
zinc finger MYND domain-containing protein 11, transcript variant X2
zinc finger MYND domain-containing protein 11 isoform X1
zinc finger MYND domain-containing protein 11 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
inactive peptidyl-prolyl cis-trans isomerase FKBP6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like, transcript variant X2
pancreatic triacylglycerol lipase-like isoform X2
pancreatic triacylglycerol lipase-like, transcript variant X1
pancreatic triacylglycerol lipase-like, transcript variant X3
pancreatic triacylglycerol lipase-like isoform X1
pancreatic triacylglycerol lipase-like isoform X3
short transient receptor potential channel 7-like
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like isoform X1
uncharacterized LOC122635703, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122635703, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X2
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X1
medium-chain acyl-CoA ligase ACSF2, mitochondrial
splicing factor U2af 38 kDa subunit-like, transcript variant X1
splicing factor U2af 38 kDa subunit-like, transcript variant X2
splicing factor U2af 38 kDa subunit-like isoform X1
splicing factor U2af 38 kDa subunit-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122635775, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122635775, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
NF-kappa-B inhibitor-interacting Ras-like protein
dihydroceramide fatty acyl 2-hydroxylase FAH2
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X3
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X1
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X2
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X2
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X1
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centrosomal protein of 89 kDa-like, transcript variant X2
centrosomal protein of 89 kDa-like, transcript variant X1
microtubule-actin cross-linking factor 1, transcript variant X23
microtubule-actin cross-linking factor 1, transcript variant X26
microtubule-actin cross-linking factor 1, transcript variant X31
microtubule-actin cross-linking factor 1, transcript variant X32
microtubule-actin cross-linking factor 1, transcript variant X47
microtubule-actin cross-linking factor 1, transcript variant X28
microtubule-actin cross-linking factor 1, transcript variant X46
microtubule-actin cross-linking factor 1, transcript variant X33
microtubule-actin cross-linking factor 1, transcript variant X48
microtubule-actin cross-linking factor 1, transcript variant X45
microtubule-actin cross-linking factor 1, transcript variant X24
microtubule-actin cross-linking factor 1, transcript variant X18
microtubule-actin cross-linking factor 1 isoform X20
microtubule-actin cross-linking factor 1 isoform X28
microtubule-actin cross-linking factor 1 isoform X40
microtubule-actin cross-linking factor 1 isoform X22
microtubule-actin cross-linking factor 1 isoform X24
microtubule-actin cross-linking factor 1 isoform X39
microtubule-actin cross-linking factor 1 isoform X27
microtubule-actin cross-linking factor 1 isoform X29
microtubule-actin cross-linking factor 1 isoform X38
microtubule-actin cross-linking factor 1 isoform X41
microtubule-actin cross-linking factor 1, transcript variant X19
microtubule-actin cross-linking factor 1, transcript variant X17
microtubule-actin cross-linking factor 1, transcript variant X16
microtubule-actin cross-linking factor 1, transcript variant X29
microtubule-actin cross-linking factor 1, transcript variant X22
microtubule-actin cross-linking factor 1, transcript variant X30
microtubule-actin cross-linking factor 1, transcript variant X42
microtubule-actin cross-linking factor 1, transcript variant X44
microtubule-actin cross-linking factor 1 isoform X16
microtubule-actin cross-linking factor 1 isoform X25
microtubule-actin cross-linking factor 1 isoform X19
microtubule-actin cross-linking factor 1 isoform X26
microtubule-actin cross-linking factor 1, transcript variant X38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
microtubule-actin cross-linking factor 1, transcript variant X39
microtubule-actin cross-linking factor 1, transcript variant X1
microtubule-actin cross-linking factor 1, transcript variant X7
microtubule-actin cross-linking factor 1, transcript variant X15
microtubule-actin cross-linking factor 1, transcript variant X27
microtubule-actin cross-linking factor 1, transcript variant X9
microtubule-actin cross-linking factor 1, transcript variant X20
microtubule-actin cross-linking factor 1, transcript variant X34
microtubule-actin cross-linking factor 1, transcript variant X14
microtubule-actin cross-linking factor 1, transcript variant X25
microtubule-actin cross-linking factor 1, transcript variant X5
microtubule-actin cross-linking factor 1, transcript variant X21
microtubule-actin cross-linking factor 1, transcript variant X2
microtubule-actin cross-linking factor 1, transcript variant X11
microtubule-actin cross-linking factor 1, transcript variant X4
microtubule-actin cross-linking factor 1, transcript variant X6
microtubule-actin cross-linking factor 1, transcript variant X3
microtubule-actin cross-linking factor 1, transcript variant X12
microtubule-actin cross-linking factor 1, transcript variant X8
microtubule-actin cross-linking factor 1, transcript variant X37
microtubule-actin cross-linking factor 1, transcript variant X10
microtubule-actin cross-linking factor 1, transcript variant X13
microtubule-actin cross-linking factor 1 isoform X1
microtubule-actin cross-linking factor 1 isoform X7
microtubule-actin cross-linking factor 1 isoform X15
microtubule-actin cross-linking factor 1 isoform X23
microtubule-actin cross-linking factor 1 isoform X9
microtubule-actin cross-linking factor 1 isoform X17
microtubule-actin cross-linking factor 1 isoform X30
microtubule-actin cross-linking factor 1 isoform X8
microtubule-actin cross-linking factor 1 isoform X32
microtubule-actin cross-linking factor 1 isoform X14
microtubule-actin cross-linking factor 1 isoform X21
microtubule-actin cross-linking factor 1 isoform X5
microtubule-actin cross-linking factor 1 isoform X18
microtubule-actin cross-linking factor 1 isoform X2
microtubule-actin cross-linking factor 1 isoform X10
microtubule-actin cross-linking factor 1 isoform X11
microtubule-actin cross-linking factor 1 isoform X4
microtubule-actin cross-linking factor 1 isoform X6
microtubule-actin cross-linking factor 1 isoform X3
microtubule-actin cross-linking factor 1 isoform X12
microtubule-actin cross-linking factor 1 isoform X13
microtubule-actin cross-linking factor 1, transcript variant X35
microtubule-actin cross-linking factor 1, transcript variant X43
microtubule-actin cross-linking factor 1, transcript variant X36
microtubule-actin cross-linking factor 1 isoform X31
microtubule-actin cross-linking factor 1 isoform X36
microtubule-actin cross-linking factor 1, transcript variant X41
microtubule-actin cross-linking factor 1 isoform X34
microtubule-actin cross-linking factor 1, transcript variant X40
microtubule-actin cross-linking factor 1 isoform X33
NF-kappa-B-repressing factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NF-kappa-B-repressing factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
NF-kappa-B-repressing factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
NF-kappa-B-repressing factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
NF-kappa-B-repressing factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ADP-ribosylation factor 6, transcript variant X2
ADP-ribosylation factor 6, transcript variant X1
ADP-ribosylation factor 6, transcript variant X5
ADP-ribosylation factor 6, transcript variant X4
ADP-ribosylation factor 6, transcript variant X3
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X4
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X3
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X2
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X9
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X10
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X1
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X7
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X6
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X5
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X8
UDP-N-acetylhexosamine pyrophosphorylase isoform X3
UDP-N-acetylhexosamine pyrophosphorylase isoform X1
UDP-N-acetylhexosamine pyrophosphorylase isoform X4
UDP-N-acetylhexosamine pyrophosphorylase isoform X2
protein abrupt-like, transcript variant X5
protein abrupt-like, transcript variant X3
protein abrupt-like, transcript variant X1
protein abrupt-like, transcript variant X2
protein abrupt-like, transcript variant X4
protein abrupt-like, transcript variant X7
protein abrupt-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein abrupt-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5-like isoform X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X3
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X7
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-1 isoform X1
voltage-dependent L-type calcium channel subunit beta-1 isoform X3
voltage-dependent L-type calcium channel subunit beta-1 isoform X2
voltage-dependent L-type calcium channel subunit beta-1 isoform X4
voltage-dependent L-type calcium channel subunit beta-2 isoform X6
voltage-dependent L-type calcium channel subunit beta-3 isoform X5
voltage-dependent L-type calcium channel subunit beta-2 isoform X7
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2 isoform X10
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X9
voltage-dependent L-type calcium channel subunit beta-2 isoform X8
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X15
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-2 isoform X9
voltage-dependent L-type calcium channel subunit beta-2 isoform X11
putative uncharacterized protein DDB_G0277255, transcript variant X2
putative uncharacterized protein DDB_G0277255, transcript variant X1
putative uncharacterized protein DDB_G0277255
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
coiled-coil domain-containing protein 113-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
glutamate decarboxylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glutamate decarboxylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glutamate decarboxylase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122635778, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122635778, transcript variant X3
uncharacterized LOC122635778, transcript variant X4
uncharacterized LOC122635778, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122635778, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeotic protein distal-less, transcript variant X1
homeotic protein distal-less, transcript variant X3
homeotic protein distal-less, transcript variant X2
homeotic protein distal-less, transcript variant X4
homeotic protein distal-less, transcript variant X5
homeobox protein MSH-D-like, transcript variant X2
homeobox protein MSH-D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
UBX domain-containing protein 4, transcript variant X1
UBX domain-containing protein 4, transcript variant X2
UBX domain-containing protein 4, transcript variant X3
UBX domain-containing protein 4 isoform X2
UBX domain-containing protein 4 isoform X1
partitioning defective 3 homolog, transcript variant X5
partitioning defective 3 homolog, transcript variant X3
partitioning defective 3 homolog, transcript variant X4
partitioning defective 3 homolog, transcript variant X1
partitioning defective 3 homolog, transcript variant X2
partitioning defective 3 homolog isoform X1
uncharacterized protein LOC122635871 isoform X2
partitioning defective 3 homolog isoform X3
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X2
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X3
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X2
ranBP-type and C3HC4-type zinc finger-containing protein 1-like isoform X1
diacylglycerol O-acyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
diacylglycerol O-acyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
diacylglycerol O-acyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
diacylglycerol O-acyltransferase 1, transcript variant X2
diacylglycerol O-acyltransferase 1 isoform X2
diacylglycerol O-acyltransferase 1 isoform X1
protein KRTCAP2 homolog, transcript variant X2
protein KRTCAP2 homolog, transcript variant X1
trinucleotide repeat-containing gene 6C protein, transcript variant X6
trinucleotide repeat-containing gene 6C protein, transcript variant X4
trinucleotide repeat-containing gene 6C protein, transcript variant X1
trinucleotide repeat-containing gene 6C protein, transcript variant X5
trinucleotide repeat-containing gene 6C protein, transcript variant X3
trinucleotide repeat-containing gene 6C protein, transcript variant X2
trinucleotide repeat-containing gene 6C protein isoform X3
trinucleotide repeat-containing gene 6C protein isoform X4
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat-containing gene 6C protein isoform X1
zinc finger protein 45-like, transcript variant X2
zinc finger protein 45-like, transcript variant X1
Bardet-Biedl syndrome 7 protein homolog, transcript variant X3
Bardet-Biedl syndrome 7 protein homolog, transcript variant X2
Bardet-Biedl syndrome 7 protein homolog, transcript variant X1
Bardet-Biedl syndrome 7 protein homolog isoform X2
Bardet-Biedl syndrome 7 protein homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog isoform X3
uncharacterized LOC122635715, transcript variant X4
uncharacterized LOC122635715, transcript variant X2
uncharacterized LOC122635715, transcript variant X3
uncharacterized LOC122635715, transcript variant X1
putative uncharacterized protein DDB_G0288537, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative uncharacterized protein DDB_G0288537, transcript variant X3
putative uncharacterized protein DDB_G0288537, transcript variant X1
putative uncharacterized protein DDB_G0288537 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ATP-binding cassette sub-family F member 2, transcript variant X1
ATP-binding cassette sub-family F member 2, transcript variant X2
ATP-binding cassette sub-family F member 2
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like, transcript variant X4
flocculation protein FLO11-like, transcript variant X16
flocculation protein FLO11-like, transcript variant X8
flocculation protein FLO11-like, transcript variant X7
flocculation protein FLO11-like, transcript variant X9
flocculation protein FLO11-like isoform X2
flocculation protein FLO11-like isoform X4
flocculation protein FLO11-like, transcript variant X10
flocculation protein FLO11-like, transcript variant X13
flocculation protein FLO11-like, transcript variant X11
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like, transcript variant X3
flocculation protein FLO11-like, transcript variant X5
flocculation protein FLO11-like, transcript variant X6
flocculation protein FLO11-like isoform X1
flocculation protein FLO11-like isoform X5
flocculation protein FLO11-like isoform X3
flocculation protein FLO11-like isoform X6
flocculation protein FLO11-like, transcript variant X12
flocculation protein FLO11-like isoform X7
flocculation protein FLO11-like isoform X8
flocculation protein FLO11-like, transcript variant X14
flocculation protein FLO11-like, transcript variant X15
flocculation protein FLO11-like isoform X9
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
iroquois-class homeodomain protein IRX-6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
homeobox protein araucan-like, transcript variant X1
homeobox protein araucan-like, transcript variant X2
homeobox protein araucan-like isoform X1
homeobox protein araucan-like isoform X2
ankyrin repeat domain-containing protein SOWAHC, transcript variant X1
ankyrin repeat domain-containing protein SOWAHC, transcript variant X3
ankyrin repeat domain-containing protein SOWAHC, transcript variant X2
ankyrin repeat domain-containing protein SOWAHC, transcript variant X4
ankyrin repeat domain-containing protein SOWAHC, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHC isoform X1
ankyrin repeat domain-containing protein SOWAHC isoform X3
ankyrin repeat domain-containing protein SOWAHC isoform X2
ankyrin repeat domain-containing protein SOWAHC isoform X4
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X2
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X1
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X2
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X1
ZZ-type zinc finger-containing protein 3
b(0,+)-type amino acid transporter 1-like, transcript variant X3
b(0,+)-type amino acid transporter 1-like, transcript variant X2
b(0,+)-type amino acid transporter 1-like, transcript variant X1
b(0,+)-type amino acid transporter 1-like
conserved oligomeric Golgi complex subunit 6, transcript variant X1
conserved oligomeric Golgi complex subunit 6, transcript variant X2
conserved oligomeric Golgi complex subunit 6 isoform X1
conserved oligomeric Golgi complex subunit 6 isoform X2
serine/threonine-protein kinase N, transcript variant X3
serine/threonine-protein kinase N isoform X3
serine/threonine-protein kinase N, transcript variant X1
serine/threonine-protein kinase N, transcript variant X2
serine/threonine-protein kinase N, transcript variant X4
serine/threonine-protein kinase N isoform X1
serine/threonine-protein kinase N isoform X2
serine/threonine-protein kinase N isoform X4
serine/threonine-protein kinase N, transcript variant X5
serine/threonine-protein kinase N isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein bunched, class 2/F/G isoform-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein bunched, class 2/F/G isoform-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein bunched, class 2/F/G isoform-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein bunched, class 2/F/G isoform-like isoform X1
protein bunched, class 2/F/G isoform-like isoform X2
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122635817, transcript variant X1
uncharacterized protein LOC122635817 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122635817, transcript variant X3
uncharacterized LOC122635817, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC122635817 isoform X3
uncharacterized protein LOC122635817 isoform X2
glutamate receptor ionotropic, delta-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor ionotropic, delta-1-like, transcript variant X3
glutamate receptor ionotropic, delta-1-like isoform X1
glutamate receptor ionotropic, delta-1-like isoform X3
glutamate receptor ionotropic, delta-1-like, transcript variant X2
glutamate receptor ionotropic, delta-1-like isoform X2
glutamate receptor ionotropic, delta-2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
glutamate receptor 1-like, transcript variant X3
glutamate receptor 1-like, transcript variant X4
glutamate receptor 1-like, transcript variant X2
glutamate receptor 1-like, transcript variant X1
uncharacterized LOC122635823, transcript variant X3
uncharacterized LOC122635823, transcript variant X1
uncharacterized LOC122635823, transcript variant X2
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytochrome P450 4C1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytochrome P450 4C1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cytochrome P450 4C1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC122635824, transcript variant X2
uncharacterized LOC122635824, transcript variant X1
uncharacterized LOC122635824, transcript variant X3
uncharacterized LOC122635825, transcript variant X2
uncharacterized LOC122635825, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments